Subscribe to RSS
Tumor rupture of gastric gastrointestinal stromal tumors during endoscopic resection: a risk factor for peritoneal metastasis?
submitted 06 November 2017
accepted after revision 14 March 2018
01 August 2018 (online)
Background and study aims Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the gastrointestinal tract. Up to the present time, complete surgical excision has been the standard treatment for primary GISTs greater than 2 cm. It is well known that tumor rupture during surgery is an independent risk factor for peritoneal metastasis; however, it is not known whether the risk of peritoneal metastasis increases in cases where the tumor is ruptured during endoscopic resection.
Patients and methods A total of 195 patients treated for GIST between January 2014 and December 2016 in our hospital were enrolled in this study. They were divided into two groups according to whether the tumor was ruptured during endoscopic resection. The rate of peritoneal metastasis in patients in the two groups who also suffered perforation was investigated from the follow-up results.
Results Approximately 55.4 % of all patients were female and the average age of the study group was 59.0 ± 10.3 years. Of the 195 patients, the tumors in 27 were ruptured and the remaining 168 patients underwent en bloc resection. There was no statistically significant difference in gender or age between the two groups. The median tumor size (maximum diameter) in all patients was 1.5 cm (0.3 – 5.0 cm): 2.5 cm (0.8 – 5.0 cm) and 1.4 cm (0.3 – 4.0 cm) in the tumor rupture group and en bloc resection group, respectively (P < 0.001). Most of the tumors were located in the gastric fundus. At a median follow-up of 18.7 ± 10.2 months, neither tumor recurrence (liver metastasis, peritoneal metastasis, local recurrence) nor mortality related to GISTs were detected.
Conclusions Tumor rupture during endoscopic resection of gastric GISTs may not be a risk factor for peritoneal metastasis.
- 1 Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006; 23: 70-83
- 2 Chourmouzi D, Sinakos E, Papalavrentios L. et al. Gastrointestinal stromal tumors: a pictorial review. J Gastrointest Liver Dis 2009; 18: 379-383
- 3 Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006; 130: 1466-1478
- 4 Beham AW, Schaefer IM, Schuler P. et al. Gastrointestinal stromal tumors. Int J Colorectal Dis 2012; 27: 689-700
- 5 Bamboat ZM, Dematteo RP. Updates on the management of gastrointestinal stromal tumors. Surg Oncol Clin N Am 2012; 21: 301-316
- 6 Karakousis GC, Singer S, Zheng J. et al. Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison. Ann Surg Oncol 2011; 18: 1599-1605
- 7 Frankel TL, Chang AE, Wong SL. Surgical options for localized and advanced gastrointestinal stromal tumors. J Surg Oncol 2011; 104: 882-887
- 8 Wilhelm D, von Delius S, Burian M. et al. Simultaneous use of laparoscopy and endoscopy for minimally invasive resection of gastric subepithelial masses – analysis of 93 interventions. World J Surg 2008; 32: 1021-1028
- 9 Novitsky YW, Kercher KW, Sing RF. et al. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg 2006; 243: 738-745 ; discussion 745–737
- 10 Kim IH, Kim IH, Kwak SG. et al. Gastrointestinal stromal tumors (GISTs) of the stomach: a multicenter, retrospective study of curatively resected gastric GISTs. Ann Surg Treat Res 2014; 87: 298-303
- 11 Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 2008; 39: 1411-1419
- 12 Rutkowski P, Nowecki ZI, Michej W. et al. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor. Ann Surg Oncol 2007; 14: 2018-2027
- 13 Dumonceau JM, Polkowski M, Larghi A. et al. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2011; 43: 897-912
- 14 Kim HH. Endoscopic treatment for gastrointestinal stromal tumor: Advantages and hurdles. World J Gastrointest Endosc 2015; 7: 192-205
- 15 Meng FS, Zhang ZH, Hong YY. et al. Comparison of endoscopic submucosal dissection and surgery for the treatment of gastric submucosal tumors originating from the muscularis propria layer: a single-center study (with video). Surg Endosc 2016; 30: 5099-5107
- 16 Schmidt A, Meier B, Caca K. Endoscopic full-thickness resection: Current status. World J Gastroenterol 2015; 21: 9273-9285
- 17 Ko WJ, Cho JY. Current techniques for treating gastrointestinal stromal tumors in the upper gastrointestinal tract. Clin Endosc 2016; 49: 226-228
- 18 Koo DH, Ryu MH, Kim KM. et al. Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor. Cancer Res Treat 2016; 48: 1155-1166
- 19 Kang GH, Srivastava A, Kim YE. et al. DOG1 and PKC-theta are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors. Mod Pathol 2011; 24: 866-875
- 20 Cichoz-Lach H, Kasztelan-Szczerbinska B, Slomka M. Gastrointestinal stromal tumors: epidemiology, clinical picture, diagnosis, prognosis and treatment. Pol Arch Med Wewn 2008; 118: 216-221
- 21 Cho MY, Sohn JH, Kim JM. et al. Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004. J Korean Med Sci 2010; 25: 853-862
- 22 Kim KH, Kim MC, Jung GJ. et al. Long term survival results for gastric GIST: is laparoscopic surgery for large gastric GIST feasible?. World J Surg Oncol 2012; 10: 230
- 23 Dai WJ, Liu G, Wang M. et al. Endoscopic versus laparoscopic resection of gastric gastrointestinal stromal tumors: a multicenter study. Oncotarget 2017; 8: 11259-11267
- 24 Takahashi T, Nakajima K, Nishitani A. et al. An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors. Int J Clin Oncol 2007; 12: 369-374
- 25 Hohenberger P, Ronellenfitsch U, Oladeji O. et al. Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg 2010; 97: 1854-1859
- 26 Ng EH, Pollock RE, Munsell MF. et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 1992; 215: 68-77
- 27 DeMatteo RP, Lewis JJ, Leung D. et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231: 51-58
- 28 Hassan I, You YN, Shyyan R. et al. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol 2008; 15: 52-59
- 29 Huang HY, Li CF, Huang WW. et al. A modification of NIH consensus criteria to better distinguish the highly lethal subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcome. Surgery 2007; 141: 748-756
- 30 Mucciarini C, Rossi G, Bertolini F. et al. Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer 2007; 7: 230